Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Internal Medicine Journal|June 1, 2012
Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancerG J McCaughan, P L Blinman, M J Boyer, et al.Internal Medicine Journal|September 24, 2005
Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancerA M Joshua, I Nordman, R Venkataswaran, et al.British Journal of Cancer|January 13, 2006
Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancerM R Stockler, M H N Tattersall, M J Boyer, et al.European Journal of Cancer (Oxford, England : 1990)|May 15, 2014
Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: a systematic review of randomised trialsT A West, B E Kiely, M R StocklerThe Medical Journal of Australia|March 31, 2001
Evidence-based medicine: useful tools for decision makingJ C Craig, L M Irwig, M R StocklerInternal Medicine Journal|March 2, 2005
Beauty is in the eye of the examiner: reaching agreement about physical signs and their valueA M Joshua, D S Celermajer, M R StocklerChest|January 23, 1998
New chemotherapeutic agents in the treatment of non-small cell lung cancer: the Australian experienceM J BoyerInternal Medicine Journal|May 8, 2015
Weighing up the benefits and harms of a new anti-cancer drug: a survey of Australian oncologistsL Chim, G Salkeld, M R Stockler, et al.Internal Medicine Journal|February 27, 2003
Outcomes research: what is it and why does it matter?M Jefford, M R Stockler, M H N TattersallPageof 9